GIP/GLP-1
Sort by:
Icahn School of Medicine at Mount Sinai
Chronic Kidney Disease and Hypertension: Panel Discussion
FEATURING
Samira Farouk,
Karim El Hachem
- 572 views
- July 10, 2023
- 5
Scripps Health
Obesity and Diabetes Pharmacotherapy: Are You Ready for GLP-1 Agonists?
FEATURING
Samantha Harris
- 1,504 views
- June 21, 2023
- 11
Sonja's Media Badge
One Size Does Not Fit All: Clinical Pearls with Medications for Weight Management
- 245 views
- June 14, 2023
- 1
Stanford Medicine
What's the Ideal Therapy for Obesity?
FEATURING
Aaron Yeoh
- 3,615 views
- June 13, 2023
- 21
The North American Thrombosis Forum (NATF)
An Internist's Perspective: Understanding Obesity and it's Management
FEATURING
Judy Shiau
- 242 views
- May 16, 2023
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4
NYU Langone
Post-Operative Anti-Obesity Medications
FEATURING
Holly Lofton
- 610 views
- March 28, 2023
- 4
Silva Arslanian
Once-Weekly Subcutaneous Semaglutide 2.4 mg in Adolescents with Obesity
- 2,050 views
- February 9, 2023
- 13
NYU Langone
Precision Medicine - With a Focus on the Science of Obesity
FEATURING
Steven Lamm
- 908 views
- January 31, 2023
- 3
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
FEATURING
Ken Fujioka
- 14,889 views
- November 28, 2022
- 72
Houston Methodist DeBakey Heart and Vascular Center
Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?
FEATURING
Kershaw Patel
- 1,913 views
- November 15, 2022
- 8
Banshi Saboo
Current & Emerging Big Molecules for Obesity: GLP-1 RA (Sema 2.4 mg, Lira 3mg), Tirzepatide, Cagrisema
- 1,272 views
- July 26, 2022
- 4
Francesco Giorgino
2021 ADA Highlights: SURPASS Program: Change in HbA1C From Baseline
- 906 views
- July 14, 2021
- 4